A biomaterials researcher from the University of London is among the winners of the 2010 Innovation in Oral Care Awards, sponsored by the International Association for Dental Research (IADR) and GlaxoSmithKline (GSK).
Robert Allaker, B.Sc., Ph.D., of the University of London Institute of Dentistry will receive a $75,000 unrestricted research grant to further his work in developing multifunctional nanobiomaterials for implant-based dental reconstruction products.
"It is well recognized that bacterial infection is a significant cause of implant failure," the IADR noted in a press release announcing the awards. "Implant coatings with durable antimicrobial properties together with enhanced bone compatibility will lead to a reduction in the total number of revisions and an increase in the expected implant life span."
Daniel Grenier, Ph.D., of Université Laval in Québec, is also being honored for his research into the therapeutic potential of citrus auraptene for periodontal disease. Auraptene is found in high amounts in citrus fruits and has been reported to possess various valuable pharmacological properties, such as antioxidant, anti-inflammatory, and antibacterial activities, the IADR noted. For a preventive approach, auraptene may be added into mouthwash or incorporated into a chewing gum. For therapeutic purposes, auraptene may be incorporated into a gel or fiber for topical application into diseased periodontal sites.
The third 2010 innovation award winner is Craig Miller, D.M.D, M.S., of the University of Kentucky College of Dentistry. Dr. Miller is developing a point-of-care immunoassay test strip for diagnosing periodontal disease that could lead to significant increases in screening for oral diseases and referrals to appropriate oral healthcare experts, according to the IADR.
The awards, which are funded by GSK, will be presented during the IADR General Session and Exhibition, to be held July 14-17, 2010, in Barcelona, Spain.
Copyright © 2010 DrBicuspid.com
